-
Part 3 | Session 1 Population Strategies for the Management of Hypertension
-
Part 3 | Session 2 ROSE: CETPi Lowers LDL-C in Patients Taking High Intensity Statins
-
Part 3 | Session 4 EAST-AFNET 4: Early Rhythm Control Was Consistent in AF Patterns
-
Part 3 | Session 5 EMPEROR-Preserved: Empagliflozin, Health Status, & QoL in Patients With HFp
-
Part 3 | Session 7 SGLT2 is Associated with Reduction in Atrial-Arrythmic Events
-
Part 3 | Session 8 SMART-CRT: Effects of AV Optimization on CRT Outcomes
-
Part 3 | Session 11 SPIRIT-HCM: Quality of Life After SM in Obstructive Patients With HCM
-
Part 1 | Session 1 AHA 2021 Late-breaker Discussion: The EMPULSE Trial
-
Part 1 | Session 2 AHA 21 Late-breaker Discussion: The CHIEF-HF Clinical Trial
Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen provide a concise and insightful preview of the late-breaking science presented at AHA Scientific Sessions 2021.
For a deep-dive, watch Dr Harriette Van Spall's Late-breaking Discussion series on highly expected trials with principal investigators.
Short, accessible Expert Interviews will be available conducted with select faculty focusing on the results, applicability, and impact on future research.
More from this programme
Part 1
Late-breaker Discussion Series
Part 2
View from the Thoraxcenter: Preview of the Late-Breaking Trials
Part 3
Expert Interviews
Faculty Biographies
Harriette Van Spall
Associate Professor of Medicine, Director of E-Health and Virtual Care
Dr Harriette Van Spall is an internationally known cardiologist, research methodologist, and senior scientist. She serves as an Associate Professor of Medicine at McMaster University, a Senior Scientist at the Population Health Research Institute, and Director of Implementation Science at the Baim Institute for Clinical Research in Boston.
Academic history
Dr Van Spall completed her BSc and MD at the University of Toronto, followed by residency and fellowship training in internal medicine and…